SCHEMBL7008053

SCHEMBL7008053

CCCCc1nc2cccc(C(=O)OC)c2n1Cc1ccc(-n2c(C)ccc2C#N)cc1

nearest known ligand 0.57

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
TLR7 Q9NYK1 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7012883 0.88 TLR7 (0.46) TLR7
SCHEMBL7008675 0.82 TLR7 (0.46) TLR7
SCHEMBL7016557 0.80 PPARG (0.58)
SCHEMBL7014291 0.79 AGTR2 (0.52)
SCHEMBL7010494 0.79 TLR7 (0.43) TLR7
SCHEMBL9194503 0.78 PPARG (0.57)
SCHEMBL7007850 0.77 AGTR2 (0.47)
SCHEMBL7010581 0.77 TLR7 (0.44) TLR7
SCHEMBL7016826 0.76 TLR7 (0.49) TLR7
SCHEMBL7014033 0.76 AGTR2 (0.72)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1327631-A2 Fused heterocyclic compounds, their production and use as angiotensin II antagonists Takeda Chemical Industries, Ltd. (JP) 2003-07-16 EP disclosed
EP-0518033-B1 Fused heterocyclic compounds, their production and use TAKEDA CHEMICAL INDUSTRIES LTD (JP) 2003-07-02 EP disclosed
US-5389641-A Fused heterocyclic compounds, having angiotensin II antagonistic activity TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 1995-02-14 US disclosed
EP-0518033-A1 Fused heterocyclic compounds, their production and use TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 1992-12-16 EP disclosed